Researcher.Life Logo

Antimicrobial Agents and Chemotherapy : Impact Factor & More

eISSN: 1098-6596pISSN: 0066-4804

Aims and Scope of Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy is a peer-reviewed scientific journal published by the American Society for Microbiology. It covers antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. The editor-in-chief is Cesar A. Arias (University of Texas Health Science Center at Houston). It was established in 1972 by Gladys Lounsbury Hobby. Less

Key Metrics

CiteScore
9.3
Impact Factor
< 5
Scite Index
0.89 5-Year SI
SJR
Q1Pharmacology
SNIP
1.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy Journal Specifications

Overview
Publisher AMER SOC MICROBIOLOGY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1953
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Antimicrobial Agents and Chemotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Antimicrobial Agents and Chemotherapy

Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Second Correction for Huang et al., "In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori".
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Case Commentary: Intraventricular polymyxin B-small steps, big questions.
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo models.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy
Population pharmacokinetic model and dosing nomogram for daptomycin in adult patients with serious Gram-positive infections: emphasizing the role of loading doses and renal function-based adjustment.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy
Antischistosomal activity of imidazolidine-2,4-dione derivatives.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Second Correction for Huang et al., "In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori".
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Case Commentary: Intraventricular polymyxin B-small steps, big questions.
  • 27 Jan 2026
  • Antimicrobial agents and chemotherapy
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo models.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy
Population pharmacokinetic model and dosing nomogram for daptomycin in adult patients with serious Gram-positive infections: emphasizing the role of loading doses and renal function-based adjustment.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy
Antischistosomal activity of imidazolidine-2,4-dione derivatives.
  • 26 Jan 2026
  • Antimicrobial agents and chemotherapy

FAQs on Antimicrobial Agents and Chemotherapy